ANIP · Ani Pharmaceuticals Inc · Documents
$72.61
-1.14 (-1.55%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$1.67B
Shares
22.97M
Volume · Oct 23
318.61K
Avg daily vol (3M)
382.32K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2026-09-15 | 2026-09-30 | |
| Investor Event Transcript | — | 2026-09-14 | 2026-09-30 | |
| Investor Event Transcript | — | 2026-09-10 | 2026-09-30 | |
| 8-K | — | 2026-08-24 | 2026-08-19 | |
| 8-K | — | 2026-08-07 | — | |
| 10-Q | — | 2026-08-07 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-06-03 | 2026-06-30 | |
| 8-K | — | 2026-05-21 | — | |
| 8-K | — | 2026-05-13 | — | |
| 10-Q | — | 2026-05-08 | 2026-03-31 | |
| 8-K | — | 2026-05-08 | — | |
| ARS | — | 2026-04-09 | 2025-12-31 | |
| DEF 14A | — | 2026-04-09 | 2025-12-31 | |
| DEFA14A | — | 2026-04-09 | — | |
| 8-K | — | 2026-04-07 | 2026-04-01 | |
| 8-K | — | 2026-03-03 | — | |
| 10-K | — | 2026-02-27 | 2025-12-31 | |
| 8-K | — | 2026-02-27 | — | |
| 8-K | — | 2026-01-12 | — | |
| 8-K | — | 2025-12-01 | 2025-11-24 | |
| 8-K | — | 2025-11-10 | — | |
| 10-Q | — | 2025-11-07 | 2025-09-30 | |
| 8-K | — | 2025-11-07 | — | |
| 8-K | — | 2025-09-26 | — | |
| 8-K | — | 2025-09-08 | — | |
| 10-Q | — | 2025-08-08 | 2025-06-30 | |
| 8-K | — | 2025-08-08 | — | |
| 8-K | — | 2025-07-29 | — | |
| 8-K | — | 2025-07-23 | — | |
| 8-K | — | 2025-07-23 | — | |
| 8-K | — | 2025-06-04 | — | |
| 8-K | — | 2025-05-23 | 2025-05-22 | |
| 8-K | — | 2025-05-20 | — | |
| 8-K | — | 2025-05-09 | — | |
| 10-Q | — | 2025-05-09 | 2025-03-31 | |
| 8-K | — | 2025-05-08 | 2025-05-06 | |
| DEFA14A | — | 2025-05-08 | — | |
| DEF 14A | — | 2025-04-10 | 2024-12-31 | |
| DEFA14A | — | 2025-04-10 | — | |
| ARS | — | 2025-04-10 | 2024-12-31 | |
| PRE 14A | — | 2025-03-31 | 2024-12-31 | |
| 8-K | — | 2025-03-18 | — | |
| 8-K | — | 2025-03-14 | — | |
| 8-K | — | 2025-03-11 | — | |
| 10-K | — | 2025-02-28 | 2024-12-31 | |
| 8-K | — | 2025-02-28 | — | |
| 8-K | — | 2025-02-05 | — | |
| 8-K | — | 2025-01-13 | — | |
| 8-K | — | 2024-11-20 | — | |
| 8-K | — | 2024-11-08 | — |
Showing 1–50 of 164 filings
Key facts
CIK
1023024
CUSIP
00182C103
13F (30d)
39 filings
39 filers
Visit website
Investor relations